-
Sector Analysis
Intraocular Lens (IOL) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Intraocular Lens (IOL) Market Report Overview The intraocular lens (IOL) market was valued at $4.48 billion in 2023 and the market will grow at more than 2% during 2023-2033. The rising prevalence of cataracts and refractive error coupled with the increasing population around the globe has compelled governments to start initiatives toward lowering the number of patients suffering from partial or complete blindness. This, in turn, will lead to an increase in the number of eye surgeries and the use...
-
Sector Analysis
Ophthalmic Viscoelastic Devices (OVD) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Ophthalmic Viscoelastic Devices (OVD) Market Report Overview The ophthalmic viscoelastic devices (OVD) market size was $1.2 billion in 2023. The market will grow at a CAGR of more than 2% during 2023-2033. Ophthalmic viscoelastic devices, also known as OVDs, are devices used during intraocular surgery, especially anterior segment surgery. These are the viscoelastic materials used to maintain space in the eye during surgery. Typically, OVDs are pre-packaged in a syringe and are applied using a small tube. Essential properties of...
-
Thematic Analysis
Pharma M&A Deals 2023 – Top Themes – Thematic Intelligence
This report analyzes the disruptive themes that have driven M&A activity in 2023 in the Pharma Sector
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Triamcinolone Acetonide in Diabetic Macular Edema
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Triamcinolone Acetonide in Diabetic Macular Edema report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Triamcinolone Acetonide in Diabetic Macular Edema Drug Details: Triamcinolone acetonide...
-
Sector Analysis
NewNew Drug Approvals and Their Contract Manufacture – 2024 Edition
This report is the 14th edition of our long-running analysis of the CMO industry, using the FDA's NDA approvals as the primary indicator of performance. New Drug Approvals and Their Contract Manufacture (formerly called "CMO Scorecard") is critical for benchmarking the performance of the contract manufacturing organization (CMO) industry and the relative performance of major CMOs. This year's edition includes a discussion of how inflation and increasing global conflict has impacted pharma manufacturers.
-
Product Insights
NewOphthalmic Imaging Equipment Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Ophthalmic Imaging equipment is used to create images to aid in the diagnosis and treatment of eye diseases. GlobalData's Medical Devices sector report, “Ophthalmic Imaging Equipment Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Ophthalmic Imaging Equipment pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Ophthalmic Imaging Equipment report provides...
-
Product Insights
Myopia – Drugs In Development, 2023
Global Markets Direct’s, ‘Myopia - Drugs In Development, 2023’, provides an overview of the Myopia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Myopia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Macular Edema – Drugs In Development, 2023
Global Markets Direct’s, ‘Macular Edema - Drugs In Development, 2023’, provides an overview of the Macular Edema pipeline landscape. The report provides comprehensive information on the therapeutics under development for Macular Edema, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Sector Analysis
Ophthalmic Lasers Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Ophthalmic Lasers Market Report Overview The ophthalmic lasers market size was $1.12 billion in 2023. The market is expected to grow at a CAGR of more than 2% during 2023-2033. Ophthalmic lasers create a uniform and coherent light that can be continuous or pulsed. The devices are used in treating a wide spectrum of diseases involving both the anterior and posterior segments of the eye for correcting refractive disorders. Ophthalmic Lasers Market Outlook, 2023-2033 ($ Billion) Â Buy the Full Report...